114 related articles for article (PubMed ID: 25228155)
1. Multimetastatic medullary thyroid carcinoma to the breast: PET/CT--mammographic-US and MR findings.
Formicola F; Riccardi A; Vigliar E; Biondi B; Accurso A; Del Vecchio W; Imbriaco M
Breast J; 2014; 20(6):653-4. PubMed ID: 25228155
[No Abstract] [Full Text] [Related]
2. Unilateral solitary breast metastasis from medullary carcinoma of thyroid detected by FDG-PET.
Basu S; Shet T
Clin Nucl Med; 2010 Jul; 35(7):512-3. PubMed ID: 20548144
[No Abstract] [Full Text] [Related]
3. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
[TBL] [Abstract][Full Text] [Related]
4. Medullary carcinoma of thyroid metastasis to breast: A cytological experience.
Devi CA; Stephen SN; Gochhait D; Shanmugam D; Dharanipragada K; Siddaraju N; Singh D
Diagn Cytopathol; 2020 Feb; 48(2):169-173. PubMed ID: 31782260
[TBL] [Abstract][Full Text] [Related]
5. Medullary Thyroid Carcinoma: Imaging.
Delorme S; Raue F
Recent Results Cancer Res; 2015; 204():91-116. PubMed ID: 26494385
[TBL] [Abstract][Full Text] [Related]
6. Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET.
Sesti A; Mayerhoefer M; Weber M; Anner P; Wadsak W; Dudczak R; Haug A; Karanikas G
Anticancer Res; 2014 Nov; 34(11):6647-54. PubMed ID: 25368270
[TBL] [Abstract][Full Text] [Related]
7. Bilateral breast lesions in a patient with medullary thyroid carcinoma.
Andreiuolo F; Suciu V; Bayou EH; Marsiglia H; Schlumberger M; Delaloge S; Vielh P
Cytopathology; 2009 Dec; 20(6):403-5. PubMed ID: 18771530
[No Abstract] [Full Text] [Related]
8. Journal Club: incidental thyroid nodules detected at imaging: can diagnostic workup be reduced by use of the Society of Radiologists in Ultrasound recommendations and the three-tiered system?
Hobbs HA; Bahl M; Nelson RC; Kranz PG; Esclamado RM; Wnuk NM; Hoang JK
AJR Am J Roentgenol; 2014 Jan; 202(1):18-24. PubMed ID: 24370125
[TBL] [Abstract][Full Text] [Related]
9. Metastatic medullary thyroid carcinoma to the breast in a patient with combined medullary and papillary carcinoma of thyroid--a case report.
Alath P; Ahmed IN; Al-Jassar A; Hussein S; Amir T; Al-Waheeb S; Al-Abdulghani R; George SS; Kapila K
Diagn Cytopathol; 2015 Apr; 43(4):343-8. PubMed ID: 25350779
[TBL] [Abstract][Full Text] [Related]
10. [Multimodal imaging in medullary thyroid carcinomas].
Müssig K; Bares R; Horger M
Rofo; 2010 Nov; 182(11):925-8. PubMed ID: 21031322
[No Abstract] [Full Text] [Related]
11. A rare case of medullary carcinoma thyroid metastasizing to bilateral breast parenchyma.
Hassan A; Siddiqui M; Jahangir S
Nucl Med Rev Cent East Eur; 2016; 19(B):17-19. PubMed ID: 27900756
[TBL] [Abstract][Full Text] [Related]
12. [Breast metastasis from medullary carcinoma of the thyroid].
Gargoura A; Khammassi N
Pan Afr Med J; 2015; 22():85. PubMed ID: 26848332
[No Abstract] [Full Text] [Related]
13. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Giraudet AL; Vanel D; Leboulleux S; Aupérin A; Dromain C; Chami L; Ny Tovo N; Lumbroso J; Lassau N; Bonniaud G; Hartl D; Travagli JP; Baudin E; Schlumberger M
J Clin Endocrinol Metab; 2007 Nov; 92(11):4185-90. PubMed ID: 17726071
[TBL] [Abstract][Full Text] [Related]
14. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
15. Can injection of pentagastrin stimulate the identification of metastases of medullary thyroid carcinoma by (18)F-FDG PET/CT?
Erdoğan MF; Demir O; Ozkan E; Küçük ON
Hell J Nucl Med; 2012; 15(2):155-6. PubMed ID: 22741153
[No Abstract] [Full Text] [Related]
16. 68Ga DOTANOC PET/CT detects medullary thyroid cancer relapse at bone level.
Nicolini S; Ambrosini V; Fantini L; Fanti S
Clin Nucl Med; 2012 Jun; 37(6):591-2. PubMed ID: 22614194
[TBL] [Abstract][Full Text] [Related]
17. The role of PET/CT in the evaluation of skeletal metastases.
Kannivelu A; Loke KS; Kok TY; Osmany SY; Ali SZ; Suat-Jin L; Ng DC
Semin Musculoskelet Radiol; 2014 Apr; 18(2):149-65. PubMed ID: 24715447
[TBL] [Abstract][Full Text] [Related]
18. Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomography.
Nofech-Mozes S; Mackenzie R; Kahn HJ; Ehrlich L; Raphael SJ
Ann Diagn Pathol; 2008 Feb; 12(1):67-71. PubMed ID: 18164420
[TBL] [Abstract][Full Text] [Related]
19. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
[TBL] [Abstract][Full Text] [Related]
20. Medullary thyroid carcinoma metastatic to the breast: mammographic appearance.
Soo MS; Williford ME; Elenberger CD
AJR Am J Roentgenol; 1995 Jul; 165(1):65-6. PubMed ID: 7785635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
